MicroBiome Therapeutics’ Glyceollin For Obesity and Diabetes Granted Patent Allowance
Diabetes, News
The opposition period prior to finalization of a patent allowance application submitted by MicroBiome Therapeutics LLC regarding the use of its glyceollin therapy for the treatment of both obesity and diabetes has expired. The ... Read more